US Patent Issued to Michael Laessig, Icahn School of Medicine at Mount Sinai, The Simons Center for Systems Biology at the Institute for Advanced Study, Memorial Sloan Kettering Cancer Center on June 17 for "Neoantigens and uses thereof for treating cancer" (American, German Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,359, issued on June 17, was assigned to Michael Laessig (New York), Icahn School of Medicine at Mount Sinai (New York), The Simons Center for Systems Biology at the Institute for Advanced Study (Princeton, N.J.) and Memorial Sloan Kettering Cancer Center (New York).

"Neoantigens and uses thereof for treating cancer" was invented by Marta Luksza (New York), Vinod P. Balachandran (New York), Arnold J. Levine (Princeton, N.J.), Jedd D. Wolchok (New York), Taha Merghoub (Jersey City, N.J.), Steven D. Leach (New York), Timothy A. Chan (New York), Benjamin D. Greenbaum (New York) and Michael Laessig (Cologne, Germany).

According to the abstract* released by the U.S. Patent & Trademark ...